MS & Immune Disorders

Filter Your Results

 

News

 

New Guidelines for MS Treatment

Daniel Kantor, MD, FAAN, FANA

May 2018—Will new guidelines address variability in the care of patients with MS?

Ocrelizumab Delays Cognitive Decline and Reduces Disease Activity and Disability Progression in Patients With MS

Wednesday, April 25, 2018—New data on ocrelizumab (OCREVUS; Genentech, South San Francisco, CA) were presented at the American Academy of Neurology this week, including results from 4 years of continuo…

New AAN Guideline: Patients With Multiple Sclerosis Should Start Treatment Early

Monday, April 23, 2018—The American Academy of Neurology (AAN) has released a new guideline for treating patients with multiple sclerosis (MS), which is endorsed by both the National Multiple Sclero…

New Data on Ocrelizumab

Monday, April 16, 2018—Researchers will be presenting, at the upcoming American Academy of Neurology (AAN) meeting beginning on April 21st, 2018, new data on the use of ocrelizumab (OCREVUS; Genente…

Depression and Multiple Sclerosis

Thomas P. Leist, MD, PhD

March/April 2018—Addressing depression may improve care for patients with multiple sclerosis.

The Benefits of Collaborative Care

Paul G. Matthew, MD, DNBPAS, FAAN, FAHS

March/April 2018— The National Academy of Medicine defines team-based care as any provision of health care by 2 or more medical professionals, who work collaboratively across settings, to a…

News

March/April 2018—Lawful Physician-Hastened Death, Hearing Loss and Cognitive Impairment, Extended-Release Amantadine, Fibromyalgia Biomarkers, Phase 3 Trial of Rimegepant for Migraine, A Blood Test for Concussion, and more.

Advances from ACTRIMS

Daniel Kantor, MD, FAAN, FANA

March/April 2018—A single-track meeting creates more interaction opportunities that may lead to future advances.

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC